ALVO
Alvotech trades as ALVO and has a market capitalization of $1.04 B, making it the #2610 largest US-listed company by market value. This page tracks Alvotech through 283 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-11 |
| 6-K | - | 2026-05-04 |
| 20-F | - | 2026-03-31 |
| 6-K | - | 2026-03-19 |
| SCHEDULE 13D/A | - | 2026-03-12 |
| 6-K | - | 2026-02-27 |
| 6-K | - | 2026-02-05 |
| 6-K | - | 2026-02-02 |
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg | Alvotech
Alvotech Announces Increase in Number of Own Shares | Alvotech
The largest companies sharing Alvotech's SEC industry classification (biological products, (no diagnostic substances)).
Alvotech (ALVO) has a market capitalization of $1.04 B as of 2026-07-09, ranking #2610 among US-listed companies.